B\u1ed9 EasySep\u2122 II ph\u00e2n t\u00e1ch t\u1ebf b\u00e0o d\u01b0\u01a1ng t\u00ednh b\u1eb1ng ph\u01b0\u01a1ng ph\u00e1p t\u1eeb t\u00ednh mi\u1ec5n d\u1ecbch.<\/p>\n
EasySep\u2122 l\u00e0 m\u1ed9t quy tr\u00ecnh t\u00e1ch t\u1ebf b\u00e0o t\u1eeb t\u00ednh mi\u1ec5n d\u1ecbch m\u1ea1nh m\u1ebd, d\u1ef1a tr\u00ean s\u1ef1 li\u00ean k\u1ebft \u0111\u1eb7c hi\u1ec7u c\u1ee7a kh\u00e1ng th\u1ec3 \u0111\u01a1n d\u00f2ng v\u1edbi t\u1ebf b\u00e0o m\u1ee5c ti\u00eau v\u00e0 h\u1ec7 th\u1ed1ng ph\u00e2n t\u00e1ch t\u1eeb t\u00ednh kh\u00f4ng c\u1ed9t \u0111\u01a1n gi\u1ea3n.<\/p>\n
B\u1ed9 ph\u00e2n t\u00e1ch t\u1ebf b\u00e0o EasySep\u2122 II \u0111\u01b0\u1ee3c thi\u1ebft k\u1ebf \u0111\u1ec3 ph\u00e2n l\u1eadp c\u00e1c t\u1ebf b\u00e0o CD34+ tinh s\u1ea1ch t\u1eeb m\u00e1u cu\u1ed1ng r\u1ed1n t\u01b0\u01a1i v\u1edbi quy tr\u00ecnh 2 b\u01b0\u1edbc \u0111\u01a1n gi\u1ea3n.\u00a0\u0110\u1ea7u ti\u00ean, c\u00e1c t\u1ebf b\u00e0o ti\u1ec1n th\u00e2n t\u1ea1o m\u00e1u \u0111\u01b0\u1ee3c l\u00e0m gi\u00e0u trong m\u00f4i tr\u01b0\u1eddng RosetteSep\u2122 Human Cord Blood CD34 Pre-Enrichment Cocktail (#15896C)<\/i> c\u00f3 ch\u1ee9a kh\u00e1ng th\u1ec3 nh\u1eadn d\u1ea1ng c\u00e1c t\u1ebf b\u00e0o mi\u1ec5n d\u1ecbch. Sau \u0111\u00f3, c\u00e1c t\u1ebf b\u00e0o CD34+ m\u1ee5c ti\u00eau \u0111\u01b0\u1ee3c g\u1eafn \u0111\u1eb7c hi\u1ec7u v\u1edbi ph\u1ee9c h\u1ee3p kh\u00e1ng th\u1ec3 Tetrameric v\u00e0 c\u00e1c h\u1ea1t t\u1eeb t\u00ednh ph\u1ee7 dextran trong b\u1ed9 EasySep\u2122 Human CD34 Positive Selection Cocktail (#18096C)<\/i>, v\u00e0 \u0111\u01b0\u1ee3c thu nh\u1eadn b\u1eb1ng nam ch\u00e2m EasySep\u2122 kh\u00f4ng c\u1ed9t. Ph\u1ee9c h\u1ee3p n\u00e0y c\u00f3 ch\u1ee9a m\u1ed9t kh\u00e1ng th\u1ec3 \u1ee9c ch\u1ebf th\u1ee5 th\u1ec3 Fc c\u1ee7a c\u00e1c t\u1ebf b\u00e0o mi\u1ec5n d\u1ecbch \u0111\u1ec3 gi\u1ea3m thi\u1ec3u s\u1ef1 li\u00ean k\u1ebft kh\u00f4ng \u0111\u1eb7c hi\u1ec7u. K\u1ebft qu\u1ea3 l\u00e0 c\u00e1c t\u1ebf b\u00e0o kh\u00f4ng mong mu\u1ed1n s\u1ebd \u0111\u01b0\u1ee3c b\u1ecf \u0111i v\u00e0 gi\u1eef l\u1ea1i c\u00e1c t\u1ebf b\u00e0o m\u1ee5c ti\u00eau trong \u1ed1ng nghi\u1ec7m. C\u00e1c t\u1ebf b\u00e0o CD34+ \u0111\u00e3 tinh s\u1ea1ch s\u1eb5n s\u00e0ng \u0111\u1ec3 s\u1eed d\u1ee5ng.<\/p>\n
N\u1ebfu ph\u00e2n l\u1eadp t\u1ebf b\u00e0o CD34+ t\u1eeb m\u00e1u t\u01b0\u01a1i ho\u1eb7c l\u1edbp buffy coat th\u00ec n\u00ean s\u1eed d\u1ee5ng b\u1ed9 ph\u00e2n t\u00e1ch ho\u00e0n ch\u1ec9nh t\u1ebf b\u00e0o CD34+ t\u1eeb m\u00e1u to\u00e0n ph\u1ea7n (Complete Kit for Human Whole Blood CD34+ Cells, #15086<\/i>).<\/p>\n
N\u1ebfu ph\u00e2n l\u1eadp t\u1ebf b\u00e0o CD34+ t\u1eeb c\u00e1c m\u1eabu kh\u00e1c, bao g\u1ed3m t\u1ebf b\u00e0o t\u1eeb m\u00e1u ngo\u1ea1i vi ho\u1eb7c t\u1ebf b\u00e0o \u0111\u01a1n nh\u00e2n t\u1ee7y x\u01b0\u01a1ng (t\u01b0\u01a1i ho\u1eb7c \u0111\u00e3 \u0111\u01b0\u1ee3c \u0111\u00f4ng l\u1ea1nh), t\u1ebf b\u00e0o \u0111\u01a1n nh\u00e2n trong m\u00e1u d\u00e2y r\u1ed1n \u0111\u00e3 \u0111\u01b0\u1ee3c \u0111\u00f4ng l\u1ea1nh, th\u00ec n\u00ean s\u1eed d\u1ee5ng b\u1ed9 ph\u00e2n t\u00e1ch d\u01b0\u01a1ng t\u00ednh EasySep\u2122 Human CD34 (EasySep\u2122 Human CD34 Positive Selection Kit, #17856<\/i>).<\/a><\/p>\n S\u1ea3n ph\u1ea9m n\u00e0y thay th\u1ebf cho b\u1ed9 ph\u00e2n t\u00e1ch d\u01b0\u01a1ng t\u00ednh EasySep \u2122 Human Cord Blood CD34 (Catalog # 18096<\/i>).<\/p>\n Ph\u00e2n l\u1eadp t\u1ebf b\u00e0o CD34+ t\u1eeb m\u00e1u d\u00e2y r\u1ed1n ng\u01b0\u1eddi<\/p>\n B\u1ed9 EasySep\u2122 II ph\u00e2n t\u00e1ch t\u1ebf b\u00e0o CD34+ t\u1eeb m\u00e1u cu\u1ed1ng r\u1ed1n ng\u01b0\u1eddi (Catalog #17896), bao g\u1ed3m:<\/p>\n M\u00f4i tr\u01b0\u1eddng Lymphoprep\u2122<\/a> ph\u00e2n l\u1eadp c\u00e1c t\u1ebf b\u00e0o \u0111\u01a1n nh\u00e2n:<\/p>\n C\u00e1c lo\u1ea1i h\u1ea1t t\u1eeb t\u00ednh mi\u1ec5n d\u1ecbch t\u01b0\u01a1ng th\u00edch:<\/p>\n Dung d\u1ecbch \u0111\u1ec7m EasySep\u2122, chai 1 L (Catalog # 20144).<\/p>\n","protected":false},"excerpt":{"rendered":" B\u1ed9 EasySep\u2122 II ph\u00e2n t\u00e1ch t\u1ebf b\u00e0o d\u01b0\u01a1ng t\u00ednh b\u1eb1ng ph\u01b0\u01a1ng ph\u00e1p t\u1eeb t\u00ednh mi\u1ec5n d\u1ecbch. T\u1ed5ng quan v\u1ec1 b\u1ed9 kit ph\u00e2n t\u00e1ch t\u1ebf b\u00e0o CD34+ t\u1eeb m\u00e1u cu\u1ed1ng r\u1ed1n EasySep\u2122 l\u00e0 m\u1ed9t quy tr\u00ecnh t\u00e1ch t\u1ebf b\u00e0o t\u1eeb t\u00ednh mi\u1ec5n d\u1ecbch m\u1ea1nh m\u1ebd, d\u1ef1a tr\u00ean s\u1ef1 li\u00ean k\u1ebft \u0111\u1eb7c hi\u1ec7u c\u1ee7a kh\u00e1ng th\u1ec3 \u0111\u01a1n<\/p>\n\u0110\u1eb7c \u0111i\u1ec3m n\u1ed5i b\u1eadt c\u1ee7a b\u1ed9 EasySep\u2122 II<\/strong><\/h3>\n
\n
\u1ee8ng d\u1ee5ng c\u1ee7a b\u1ed9 EasySep\u2122 II<\/strong><\/h3>\n
Th\u00f4ng tin \u0111\u1eb7t h\u00e0ng<\/strong><\/h3>\n
\n
C\u00e1c s\u1ea3n ph\u1ea9m y\u00eau c\u1ea7u ch\u1ecdn th\u00eam:<\/strong><\/h3>\n
\n
\n